基于cAMP/PKA/CREB通路探索卡巴马西平降低丸激素水平的机制
Jingya Li1, Ziao Liu1, Min Pan1
1School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, 230012 China.
3 Biotech
|November 22, 2024
概括
卡巴马兹 (CBZ) 通过破坏cAMP/PKA/CREB通路和类固醇酶来损害老鼠丸并降低丸水平. 激活PKA部分扭转了这些影响,表明CBZ毒性的关键机制.
科学领域:
- 生殖毒理学 生殖毒理学
- 内分泌学 在内分泌学.
- 分子药理学分子药理学
背景情况:
- 卡巴马西平 (CBZ) 是一种抗药物,已知具有生殖方面的副作用.
- 丸毒性和激素降低是与CBZ使用相关的重大问题.
研究的目的:
- 在大鼠中阐明CBZ诱导的丸毒性和丸降低的分子机制.
- 研究cAMP/PKA/CREB信号通路对CBZ对的合成影响中的作用.
主要方法:
- 鼠被CBZ (200 mg/kg) 治疗了12周;R2C细胞被CBZ (0.5-1.5 mM) 暴露.
- 采用了组织病理学 (HE),细胞灭绝试验 (Tunel),ELISA,免疫光学,RT-qPCR和西式斑点检测.
- 评估了对精子质量,丸结构,丸水平和类固醇酶的影响.
主要成果:
- CBZ显著损害了丸结构,诱导了亡,并降低了精子质量.
- CBZ降低了关键合成酶 (STAR,TSPO,17β-HSD,3β-HSD) 的下调,并抑制了cAMP/PKA/CREB通路蛋白.
- Db-cAMP (PKA激活剂) 治疗缓解了CBZ诱导的丸激素减少和增加PKA/p-CREB表达.
结论:
- 通过抑制cAMP/PKA/CREB通路,CBZ诱导丸毒性和丸降低.
- 这种抑制会影响类固醇生成酶的表达,导致的合成减少.
- 针对cAMP/PKA/CREB通路可能为CBZ诱导的生殖毒性提供治疗策略.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
Testosterone: Functions and Regulation
555
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
555
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


